Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION)
Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION)
Active, not recruiting · NCT06460844 · Registry updated 2026-02-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, X-linked disease, choroideremia, eye disorder, hereditary disease, inherited retinal dystrophy, optic choroid disorder, retinal degeneration, retinal disorder, retinitis pigmentosa, uveal disorder | Active, not recruiting | Phase 1 | 2026-02-20 | NCT06460844 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ray Therapeutics, Inc. | 4 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Retina Consultants of Texas Research Centers | Bellaire | United States | 2 |
| Retina Vitreous Associates Medical Group | Beverly Hills | United States | 10 |
| UCI Alpha Clinic | Orange | United States | 1 |
| UPMC Vision Institute | Pittsburgh | United States | 1 |